ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Cheap Shares
Top brokers pick shares to buy this week
⏸️ Best ASX Shares
Happy Australia Day!
Share Market News
3 ASX 100 healthcare shares to buy and hold beyond 2022
Share Market News
Where to invest $1,000 into ASX shares right now
Record Highs
Why the Polynovo share price surged to a record today
Healthcare Shares
2 ASX healthcare shares to buy and hold until 2025
Share Market News
2 leading ASX healthcare shares that should be on your radar
Share Market News
ASX 200 breaks through the 7,000 points level
Share Market News
Here's why I think this top ASX 100 healthcare share is a buy
Share Market News
3 ASX shares for the ethical investor
Growth Shares
3 five-star ASX shares to own in 2020
Healthcare Shares
Why I believe this ASX healthcare share will be a winner through to 2030
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
